Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBRX Forte BioSciences Inc

已收盘 11-21 16:00:00 EST

15.64

+2.09

+15.42%

盘后15.83

+0.19+1.21%

19:59 EST

最高15.95	最低10.11	成交量127.25万
今开12.25	昨收13.55	日振幅43.10%
总市值2,284万	流通市值1,434万	总股本146.02万
成交额1,684万	换手率138.74%	流通股本91.71万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBRX","market":"US","secType":"STK","nameCN":"Forte BioSciences Inc","latestPrice":15.64,"timestamp":1732222800000,"preClose":13.55,"halted":0,"volume":1272458,"hourTrading":{"tag":"盘后","latestPrice":15.8299,"preClose":15.64,"latestTime":"19:59 EST","volume":17756,"amount":269599.2258,"timestamp":1732237198622},"delay":0,"floatShares":917127,"shares":1460157,"eps":-18.529116,"marketStatus":"已收盘","marketStatusCode":5,"change":2.09,"latestTime":"11-21 16:00:00 EST","open":12.25,"high":15.95,"low":10.1101,"amount":16843853.567706,"amplitude":0.430989,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-18.529116,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1492056000000,"adjPreClose":13.55,"preHourTrading":{"tag":"盘前","latestPrice":11.9103,"preClose":13.55,"latestTime":"09:29 EST","volume":48043,"amount":583150.401999,"timestamp":1732199386458},"postHourTrading":{"tag":"盘后","latestPrice":15.8299,"preClose":15.64,"latestTime":"19:59 EST","volume":17756,"amount":269599.2258,"timestamp":1732237198622},"volumeRatio":0.214567,"impliedVol":1.416,"impliedVolPercentile":0.1927},"requestUrl":"/m/hq/s/FBRX","defaultTab":"news","newsList":[{"id":"2485979154","title":"Forte Biosciences, Inc.盘中异动 早盘股价大跌8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485979154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485979154?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199480,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分，Forte Biosciences, Inc.股票出现波动，股价快速跳水8.56%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122312095be4e52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122312095be4e52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","AA","BK4153","BK4588","FBRX"],"gpt_icon":0},{"id":"2485121280","title":"BUZZ-Forte Biosciences 业绩飙升；公司称 5,300 万美元私募股票获得超额认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2485121280","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485121280?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:20","pubTimestamp":1732130445,"startTime":"0","endTime":"0","summary":"11月20日 -  ** 药物开发商 Forte Biosciences FBRX.O股价上涨 132.4% 至 13.77 美元 ** 公司称价值 5300 万美元的私募股票获得超额认购   ** 资金用于支持公司开发治疗自身免疫性疾病的试验性药物 FB102 - FBRX ** 获得了新老投资者的支持，包括 OrbiMed、Janus Henderson Investors 和 Tybourne Capital Management - 首席执行官 Paul Wagner ** 尽管本交易日股价上涨，但今年以来股价下跌了 34.2(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBRX","JHG","BK4135","BK4139"],"gpt_icon":0},{"id":"2484279117","title":"Forte Biosciences, Inc.股价飙升74.85% 市值跌50.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484279117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484279117?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:30","pubTimestamp":1732113012,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时30分，Forte Biosciences, Inc.股票出现波动，股价急速拉升74.85%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223012971a7a9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223012971a7a9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4153","BK4585","AA","FBRX","BK4588"],"gpt_icon":0},{"id":"2484924364","title":"Forte Biosciences, Inc.盘中异动 急速跳水9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484924364?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:49","pubTimestamp":1732031384,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时49分，Forte Biosciences, Inc.股票出现异动，股价快速跳水9.24%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119234945971a7799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119234945971a7799&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4153","FBRX","AA","BK4588"],"gpt_icon":0},{"id":"2484154672","title":"Forte Biosciences, Inc.盘中异动 快速上涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484154672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484154672?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:37","pubTimestamp":1731944277,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时37分，Forte Biosciences, Inc.股票出现异动，股价快速拉升6.30%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233757abccca8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233757abccca8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","BK4585","BK4588","AA","FBRX","BK4139"],"gpt_icon":0},{"id":"2483807867","title":"Forte Biosciences, Inc.盘中异动 早盘快速下挫5.08%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483807867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483807867?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:07","pubTimestamp":1731596825,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时07分，Forte Biosciences, Inc.股票出现异动，股价急速下挫5.08%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230705971a695b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230705971a695b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","AA","BK4139","BK4007","PULM","FBRX","BK4588","BK4585","ELAB","BK4183"],"gpt_icon":0},{"id":"2483588117","title":"Forte Biosciences, Inc.盘中异动 早盘股价大跌7.34%报5.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483588117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483588117?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:42","pubTimestamp":1731508929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时42分，Forte Biosciences, Inc.股票出现异动，股价大幅下挫7.34%。截至发稿，该股报5.26美元/股，成交量197股，换手率0.01%，振幅0.00%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322420998e425f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322420998e425f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4153","BK4588","AA","FBRX"],"gpt_icon":0},{"id":"2481483606","title":"Forte Biosciences Inc   预计每股亏损7.12美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483606","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481483606?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:48","pubTimestamp":1731080927,"startTime":"0","endTime":"0","summary":"   * Forte Biosciences Inc    预计在11月11日公布截至2024年9月30日的财报时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Forte Biosciences Inc 每股亏损 7.12 美元。* 华尔街对 Forte Biosciences Inc 的 12 个月目标价中位数为 150.00 美元，高于其最新收盘价 4.81 美元。11月8日 - 本摘要于北京时间11月8日15:48由机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Forte Biosciences Inc   预计每股亏损7.12美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBRX"],"gpt_icon":0},{"id":"2481011391","title":"Forte Biosciences, Inc.盘中异动 早盘股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481011391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481011391?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076361,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Forte Biosciences, Inc.股票出现异动，股价快速下挫5.58%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为383.72%、16.45%、14.03%，振幅较大的相关个股有Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.、Cardiff Oncology, Inc.，振幅分别为16.51%、14.96%、14.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324195bdef2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324195bdef2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","FBRX","BK4153","BK4139","AA","BK4585"],"gpt_icon":0},{"id":"2481545415","title":"Forte Biosciences, Inc.盘中异动 快速上涨6.35%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481545415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481545415?lang=zh_cn&edition=full","pubTime":"2024-11-05 04:57","pubTimestamp":1730753831,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日04时57分，Forte Biosciences, Inc.股票出现异动，股价急速上涨6.35%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504571198e405a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504571198e405a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","AA","BK4139","BK4588","BK4585","FBRX"],"gpt_icon":0},{"id":"2480505541","title":"Forte Biosciences, Inc.盘中异动 急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480505541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480505541?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:42","pubTimestamp":1730392935,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时42分，Forte Biosciences, Inc.股票出现波动，股价快速下跌5.08%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.40%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101004215971a39bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101004215971a39bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","BK4139","FBRX","BK4588","BK4585","AA"],"gpt_icon":0},{"id":"2478993330","title":"Forte Biosciences, Inc.盘中异动 股价大涨5.40%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478993330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478993330?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863079,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Forte Biosciences, Inc.股票出现波动，股价大幅拉升5.40%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311995bd58ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311995bd58ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBRX","AA","ELAB","BK4585","BK4588","BK4153","BK4183"],"gpt_icon":0},{"id":"2477653192","title":"Forte Biosciences, Inc.盘中异动 股价大跌7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477653192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477653192?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:47","pubTimestamp":1729781260,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时47分，Forte Biosciences, Inc.股票出现异动，股价大幅下跌7.04%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024224740971a2184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024224740971a2184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","BK4139","FBRX","BK4588","BK4585","AA"],"gpt_icon":0},{"id":"2477351809","title":"Forte Biosciences, Inc.盘中异动 大幅上涨5.17%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477351809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477351809?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:06","pubTimestamp":1729609604,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时06分，Forte Biosciences, Inc.股票出现波动，股价快速拉升5.17%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Indaptus Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4492.81%、4020.65%、1955.43%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为170.68%、99.41%、81.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230644971a1a24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230644971a1a24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4153","BK4588","BK4585","BK4139","FBRX"],"gpt_icon":0},{"id":"2476525013","title":"Forte Biosciences, Inc.盘中异动 早盘股价大涨9.13%报4.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476525013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476525013?lang=zh_cn&edition=full","pubTime":"2024-10-18 23:11","pubTimestamp":1729264261,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日23时11分，Forte Biosciences, Inc.股票出现异动，股价大幅拉升9.13%。截至发稿，该股报4.91美元/股，成交量1175股，换手率0.08%，振幅0.00%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101823110195b2bdb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101823110195b2bdb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBRX","BK4588","BK4139","BK4153","AA","BK4585"],"gpt_icon":0},{"id":"2474201553","title":"Forte Biosciences, Inc.盘中异动 大幅跳水6.02%报4.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474201553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474201553?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:07","pubTimestamp":1728659229,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时07分，Forte Biosciences, Inc.股票出现波动，股价急速跳水6.02%。截至发稿，该股报4.52美元/股，成交量3668股，换手率0.25%，振幅5.00%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123071098e3be8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123071098e3be8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4139","FBRX","BK4588","BK4153","BK4585"],"gpt_icon":0},{"id":"2472104976","title":"Forte Biosciences, Inc.盘中异动 早盘大幅下跌5.78%报4.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472104976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472104976?lang=zh_cn&edition=full","pubTime":"2024-10-03 23:09","pubTimestamp":1727968189,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时09分，Forte Biosciences, Inc.股票出现波动，股价急速下挫5.78%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003230950a1de284f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003230950a1de284f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4153","FBRX","BK4183","AA","BK4139","ELAB","BK4588","BK4585"],"gpt_icon":0},{"id":"2471852343","title":"Forte Biosciences, Inc.盘中异动 股价大跌7.75%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471852343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471852343?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:50","pubTimestamp":1727704252,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时50分，Forte Biosciences, Inc.股票出现波动，股价快速下跌7.75%。截至发稿，该股报5.30美元/股，成交量660股，换手率0.05%，振幅2.79%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215052a1ddb53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215052a1ddb53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4585","BK4153","BK4588","FBRX","BK4139"],"gpt_icon":0},{"id":"2470373084","title":"Forte Biosciences, Inc.盘中异动 急速拉升11.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470373084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470373084?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:43","pubTimestamp":1727444634,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时43分，Forte Biosciences, Inc.股票出现波动，股价大幅上涨11.00%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927214354a1dd113c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927214354a1dd113c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4153","AA","BK4585","FBRX"],"gpt_icon":0},{"id":"2470260198","title":"Forte Biosciences, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470260198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470260198?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:10","pubTimestamp":1727280614,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时10分，Forte Biosciences, Inc.股票出现波动，股价急速下挫5.29%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926001014ab65ed9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926001014ab65ed9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AA","BK4585","BK4153","BK4588","FBRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortebiorx.com","stockEarnings":[{"period":"1week","weight":1.3898},{"period":"1month","weight":1.9203},{"period":"3month","weight":0.6991},{"period":"6month","weight":-0.0654},{"period":"1year","weight":0.2532},{"period":"ytd","weight":-0.3404}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Forte Biosciences, Inc.是一家临床阶段的皮肤病学公司，致力于开发用于治疗炎症性皮肤病的活体生物疗法FB-401。 FB-401已完成对成人和儿童（3岁及以上）特应性皮炎患者的1/2a期测试。 对于安全和有效的疗法，特别是对于小儿特应性皮炎患者，存在大量的需求。Forte计划在2020年代中期将FB-401推进到2期临床试验中。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":0.005676},{"month":2,"riseRate":0.428571,"avgChangeRate":0.196656},{"month":3,"riseRate":0.571429,"avgChangeRate":0.044737},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.054809},{"month":5,"riseRate":0.5,"avgChangeRate":-0.051073},{"month":6,"riseRate":0.25,"avgChangeRate":-0.035182},{"month":7,"riseRate":0.25,"avgChangeRate":-0.022505},{"month":8,"riseRate":0.5,"avgChangeRate":0.004355},{"month":9,"riseRate":0.25,"avgChangeRate":-0.165044},{"month":10,"riseRate":0.125,"avgChangeRate":-0.154936},{"month":11,"riseRate":0.5,"avgChangeRate":0.273037},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.015906}],"exchange":"NASDAQ","name":"Forte BioSciences Inc","nameEN":"Forte BioSciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Forte BioSciences Inc(FBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Forte BioSciences Inc,FBRX,Forte BioSciences Inc股票,Forte BioSciences Inc股票老虎,Forte BioSciences Inc股票老虎国际,Forte BioSciences Inc行情,Forte BioSciences Inc股票行情,Forte BioSciences Inc股价,Forte BioSciences Inc股市,Forte BioSciences Inc股票价格,Forte BioSciences Inc股票交易,Forte BioSciences Inc股票购买,Forte BioSciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Forte BioSciences Inc(FBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Forte BioSciences Inc(FBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}